IRIS
Stainer, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.935
AS - Asia 1.121
EU - Europa 468
SA - Sud America 148
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 62
OC - Oceania 7
Totale 3.827
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.873
SG - Singapore 602
CN - Cina 261
IT - Italia 145
VN - Vietnam 117
BR - Brasile 115
FI - Finlandia 53
GB - Regno Unito 41
NG - Nigeria 41
CA - Canada 40
FR - Francia 40
DE - Germania 38
IE - Irlanda 33
HK - Hong Kong 32
IN - India 29
SE - Svezia 28
MK - Macedonia 20
BD - Bangladesh 15
AR - Argentina 14
NL - Olanda 14
PL - Polonia 11
PH - Filippine 9
RU - Federazione Russa 9
IQ - Iraq 8
MX - Messico 8
ZA - Sudafrica 8
VE - Venezuela 7
AU - Australia 6
ES - Italia 6
ID - Indonesia 6
UA - Ucraina 6
CO - Colombia 5
JP - Giappone 5
MY - Malesia 5
PK - Pakistan 5
TR - Turchia 5
CR - Costa Rica 4
DZ - Algeria 3
HN - Honduras 3
LT - Lituania 3
LV - Lettonia 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KY - Cayman, isole 1
KZ - Kazakistan 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 3.741
Salva come PNG Salva come JPEG
Città #
Singapore 261
Ashburn 201
San Jose 172
Chandler 104
Shanghai 104
New York 90
The Dalles 79
Beijing 77
Dallas 74
Santa Clara 64
Boardman 60
Council Bluffs 60
Helsinki 53
Milan 52
Los Angeles 48
Benin City 41
Ho Chi Minh City 37
Dublin 34
Hong Kong 31
Princeton 28
Hanoi 27
Lawrence 26
Paris 21
Charlotte 19
Atlanta 16
Naples 16
Wilmington 14
São Paulo 13
Boston 12
London 12
Phoenix 12
Buffalo 11
Chicago 11
San Francisco 11
Seattle 10
Cleveland 9
Da Nang 9
Philadelphia 9
Skopje 9
Stockholm 9
Assago 8
Brownsville 8
Sacramento 8
Falkenstein 7
Frankfurt am Main 7
Houston 7
North Bergen 7
Pune 7
Warsaw 7
Amsterdam 6
Brooklyn 6
Chennai 6
Mexico City 6
Montreal 6
Rio de Janeiro 6
Rome 6
San Antonio 6
Toronto 6
Bitola 5
Dhaka 5
Erbil 5
Eustis 5
Johannesburg 5
Leawood 5
Miami 5
Milwaukee 5
Orem 5
Severn 5
Sydney 5
Abbeville 4
City of London 4
Denver 4
Ely 4
Greeley 4
Kansas City 4
Las Vegas 4
Mumbai 4
Pasadena 4
Vacaville 4
Yukon 4
Ankara 3
Athens 3
Biên Hòa 3
Bogotá 3
Bologna 3
Buenos Aires 3
Calgary 3
Converse 3
Detroit 3
Greeneville 3
Hải Dương 3
Kuala Lumpur 3
Oklahoma City 3
Olongapo City 3
Plano 3
Prilep 3
Riga 3
San Diego 3
San José 3
San Mateo 3
Totale 2.225
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 232
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 150
COVID-19 in Immunocompromised Patients: A Systematic Review 120
Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults 115
Cardiovascular Complications in Community-Acquired Pneumonia 114
Treatable traits in interstitial lung diseases: a call to action 106
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 95
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 93
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 91
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma 90
Identifying risk factors and pathogens in postoperative pneumonia after lung surgery for cancer: a retrospective cohort study 87
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 86
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 86
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 86
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 85
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 84
Early or delayed bronchoscopy in patients admitted to the emergency department for mild-to-moderate hemoptysis? 80
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 77
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 77
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 76
Long-Term Outcomes in Severe Community-Acquired Pneumonia 73
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 73
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 72
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 72
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions 72
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 71
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 71
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 71
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 71
Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview 69
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 68
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 68
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 67
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 66
Walking the path of treatable traits in interstitial lung diseases 64
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 64
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 62
Treatable Traits in Systemic Sclerosis 61
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 61
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 59
Diagnostic delay in bronchiectasis: an Italian perspective 56
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 54
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 51
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 50
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 49
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation 46
Response to: are there over 200 distinct types of interstitial lung diseases? 46
Bronchiectasis in Italy: an analysis of the EMBARC registry 27
Global Variation in Pneumonia Epidemiology 26
Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature 20
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study 17
Totale 3.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022108 0 0 0 2 0 0 1 2 23 44 31 5
2022/2023366 53 12 46 9 40 22 17 30 61 42 27 7
2023/2024437 38 16 66 42 10 75 33 18 18 17 41 63
2024/2025589 11 6 9 14 14 72 45 25 132 118 65 78
2025/20261.511 197 83 78 92 85 66 384 94 92 131 110 99
2026/2027781 216 98 323 144 0 0 0 0 0 0 0 0
Totale 3.827